Business Development Drug Delivery In-Vivo Life Science 
Drug Discovery World
NOVEMBER 9, 2023
The first three include: Sungjin Park, PhD, CEO, Onegene Biotechnology, on: ‘UniStac: Enzyme-mediated conjugation technology for accelerated development of tetraspecific NASH drug’. Croasdale-Wood will then participate in a keynote chat, interviewed by Miho.
XTalks
OCTOBER 1, 2020
And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.
Expert insights. Personalized for you.
52 
Let's personalize your content